May 4, 2018 8:00 am EDT VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update
Mar 13, 2018 4:05 pm EDT VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock
Mar 7, 2018 8:30 am EST VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board
Mar 1, 2018 4:05 pm EST VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update
Feb 28, 2018 4:05 pm EST VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update
Feb 26, 2018 4:05 pm EST VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer
Feb 5, 2018 8:30 am EST VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark.
Jan 3, 2018 8:30 am EST VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone
